Olmesartan Medoxomil-hydrochlorothiazide Tablet, Film Coated
Product Images NDC 73190-079

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil-hydrochlorothiazide (NDC 73190-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (078 90)

1 (078 90)
Label for olmesartan medoxomil-hydrochlorothiazide tablets, film coated, containing 20 mg of olmesartan medoxomil and 12.5 mg of hydrochlorothiazide. The label indicates 90 tablets per bottle, for oral use, labeled by AvKARE. Additional details include dosage information and storage instructions.*
FDA Label Image

1 (079 90)

1 (079 90)
Packaging label for Olmesartan Medoxomil Hydrochlorothiazide 40 mg/12.5 mg film-coated tablets by AvKARE. The label shows 90 tablets in the bottle, with dosage instructions referencing a 12.5 mg dose. It includes manufacturer details, a barcode, and the statement "Rx Only."*
FDA Label Image

1 (080 90)

1 (080 90)
Packaging label for Olmesartan Medoxomil-Hydrochlorothiazide 40 mg/25 mg film-coated tablets by AvKARE. The label shows the brand and generic names, strength, package size of 90 tablets, and indicates the medication is for oral use and prescription-only. The AvKARE logo and NDC code 73190-080-90 are visible.*
FDA Label Image

1 (How Supplied 1)

1 (How Supplied 1)
A data table describing the physical characteristics of Benicar HCT tablets containing olmesartan medoxomil and hydrochlorothiazide. It lists strength combinations, tablet shapes, colors, and debossing on side 1, with side 2 being plain. Strengths include 20/12.5 mg (round, reddish-yellow, debossed C22), 40/12.5 mg (oval, reddish-yellow, debossed C23), and 40/25 mg (oval, pink, debossed C25).*
FDA Label Image

1 (How Supplied 2)

1 (How Supplied 2)
A data table showing National Drug Code (NDC) availability for olmesartan medoxomil-hydrochlorothiazide tablets in different strengths: 20/12.5 mg, 40/12.5 mg, and 40/25 mg. The table lists packaging options (bottles of 30, 90, and 1000 tablets) and indicates which NDC codes correspond to each packaging and strength. Only bottles of 90 tablets have available NDC codes for 20/12.5 mg (078-90), 40/12.5 mg (079-90), and 40/25 mg (080-90) strengths; all other combinations are marked not available.*
FDA Label Image

Structural Formula (Benicar Hct 01)

Structural Formula (Benicar Hct 01)
Chemical structure of olmesartan medoxomil-hydrochlorothiazide, showing molecular bonds and ring structures typical of its active ingredient components.*
FDA Label Image

Hctz Structure (Benicar Hct 02)

Hctz Structure (Benicar Hct 02)
Chemical structure of olmesartan medoxomil-hydrochlorothiazide, the active ingredient in the prescription drug olmesartan medoxomil-hydrochlorothiazide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.